Philippines medical device regulations

Citizen’s-charter sheet for initial Certificate of Medical Device Registration (CMDR) applications: fee Php 7,500.00, 5-year validity, a 12-item checklist of requirements (notarized application form, letter of authorization, proof of business registration, ISO 13485 certificate, and CESP/other technical documents per AO 2018-0002 Annexes), and the client-steps process table totalling 80 working days.

Citizen’s-charter sheet (section XVI of the FDA charter compilation) for the initial License to Operate for medical device traders, distributors, wholesalers, and importers via the FDA eServices portal: a 5-item checklist (application per AO 2020-0017, proof of business registration, site master file, and LTO fees scaled to capitalization) and the client-steps process table totalling 14 working days.

FDA Circular 2021-017 publishes the reference list of Class A medical devices. The official 32-page scan remains available. The proposed transcription omits table rows and corrupts device names; it is excluded from the citeable corpus pending a complete verified transcription.

Administrative Order No. 2018-0002 (26 January 2018): guidelines governing the issuance of an authorization for a medical device based on the ASEAN Harmonized Technical Requirements — Sections I-XV (rationale, scope, definitions, general/specific/procedural guidelines, fees, phased implementation, sanctions, appeal, confidentiality, separability, repealing, effectivity) plus Annexes A-K (legal and technical requirements, application forms, and an example submission). The official FDA file is a scan whose embedded OCR layer fragments into one-word lines; the corpus reassembles it through strictly-sequenced heading promotion, so occasional OCR concatenations (e.g. "SAN CTIONS") are preserved as-published.

FDA Philippines under Department of Health regulates medical devices. Responsible for device registration, establishment licensing, and post-market surveillance.

Post-market surveillance requirements including adverse event reporting, field safety corrective actions, and medical device advisories.

Republic Act No. 9711, the Food and Drug Administration (FDA) Act of 2009: renames BFAD the FDA and amends RA 3720 across Sections 1-28 — objectives, powers, prohibited acts, penalties, a Regulatory Enforcement Unit, retained income, Congressional oversight, and the effectivity clause. The recorded FDA page URL serves the official gazette-style scan (27 pages) as PDF bytes; the site’s WAF blocks non-browser user agents on that route, so retrieval uses a standard browser UA against the same official URL. Scan OCR artifacts (e.g. "SIX. 9." for "SEC. 9.") are corrected positionally by the parser, not by editing text.